Share Recommendations

e-therapeutics SPECULATIVE BUY 12/02/2010

Professor Malcolm Young, the founder of drug discoverer e-therapeutics, is nearing the sort of development partnership or licensing deal that could take the company into profitability.

Tags: AIM , Buy/Hold , Deals & contracts , Speculative punts

Sector: Pharmaceuticals & Biotechnology

Companies: e-Therapeutics

Matchtech Group SPECULATIVE BUY 10/02/2010

Amid highly testing trading conditions, technical recruiter Matchtech is drawing strength from its contractor-led focus and ability to source skilled and sought-after workers.

Tags: AIM , Cash , Dividends , Speculative punts

Sector: Support Services

Companies: Matchtech

Care UK HOLD 10/02/2010

Health and social care provider Care UK reports satisfactory trading progress as management buy-out talks involving Bridgepoint Capital continue.

Tags: AIM , Debt , Growth Stocks

Sector: Health Care Equipment & Services

Companies: Care UK

CVS’s pet growth project 10/02/2010

Vet market consolidator CVS offers investors exciting acquisition-driven growth in a market continuing to demonstrate high-levels of recessionary resilience, writes James Crux

Norcon: Dial N for income 10/02/2010

Buoyed by its strong Middle East ties, telecoms consultant Norcon has comfortably ridden out the recession and now looks to recovery in Europe and the fast-growing markets of Asia and Africa to boost its impressive organic growth.

Fiberweb regains its fitness and focus 10/02/2010

Having emerged from a major restructuring, fabric producer Fiberweb, whose materials find their way into everything from nappies and water filters to industrial wipes and construction products, is now fitter and fully focused on some attractive global markets.

Fairpoint gets on top of its debts 09/02/2010

Debt management and finance specialist Fairpoint Group is building on a turnaround in its fortunes engineered by chief executive officer Chris Moat, and hopes to show that its mix of products and services make it more than simply a beneficiary of recession.

Green Compliance goes for growth 09/02/2010

Refocused property regulation business Green Compliance, chaired by Bob Holt, has raised £10 million from enthusiastic City backers to finance acquisitions in attractive ‘blue-collar’ compliance markets.

Lower voltages spark Cinpart 09/02/2010

A dramatic revival has been gathering momentum in the affairs of electrical components maker Cinpart, hitherto a loss-making manufacturing concern with a production base in Thailand, which transformed its profile
and prospects last March by establishing a new energy-efficient subsidiary, Active Energy.

System C Healthcare BUY 09/02/2010

A software and services provider to the healthcare industry, System C is confident that whatever the imminent General Election throws up, there will still be increasing demand for its wares.

Tags: AIM , Buy/Hold , Growth Stocks

Sector: Software & Computer Services

Companies: System C Healthcare

Alliance Pharma HOLD 09/02/2010

Fast-growing Alliance Pharma is to buy most of Cambridge Laboratories' trade and assets for £14.3m and £16.4m.

Tags: AIM , Dividends , Growth Stocks , Mergers & acquisitions

Sector: Pharmaceuticals & Biotechnology

Companies: Alliance Pharma

May Gurney Integrated Services STRONG BUY 09/02/2010

Investors seeking to back a business with exceptionally high earnings visibility and a burgeoning order book should look no further than Norwich-based infrastructure services specialist May Gurney.

Tags: AIM , Deals & contracts , Defensive , Growth Stocks

Sector: Support Services

Companies: May Gurney Integrated Services

AIM in Review 2010

Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.

M&A on AIM 2009 - Which are the most active sectors for M&A? Which are the most active brokers to follow?

M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.

Free – Latest Stock Recommendations

Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.

Select your level of risk and we select the funds

Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.

The AIM Guide 2009/10

The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!

VCT Special Report 2009

This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.

Cash Shells Special Report 2009

Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.

Share recommendations and small-cap stock picks

Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.